New Delhi: In an effort to expand its base, Consumer healthcare firm Strides Consumer on Friday said it has entered into North Indian market with oral nicotine replacement therapy and topical analgesic segments.
The company currently has strong presence in states like Karnataka, Andhra Pradesh, Telangana, Tamil Nadu, Kerala, West Bengal, Madhya Pradesh, Chhattisgarh, Odisha and Assam.
“We have forayed in the market in North as it is a large market in terms of size and consumers here are quite open to trying new products,” Strides Consumer Pvt Ltd CEO Subodh Marwah.
The company plans to expand its presence in western region too, he added.
“The expansion into the new geographic sphere testifies our vision to take our brand and products to every customer in the nation,” Marwah said.
As part of the foray, the company has launched two products Nixit, a oral nicotine replacement therapy (NRT) product, and Jointflex, a topical analgesic cream for joint care, Strides Consumer said.
Started in 2017, Strides Consumer Pvt Ltd has two marquee investors India Life Sciences Fund, which holds around 74 per cent stake in the company, and Strides Pharma Science Ltd which holds the remaining stake of around 26 per cent.